No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CYRX240517P15000
- 1.40
- -0.10-6.67%
15min DelayClose May 16 15:57 ET
1.55High1.05Low
1.05Open1.50Pre Close500 Volume801 Open Interest15.00Strike Price67.43KTurnover151.81%IV-0.44%PremiumMay 17, 2024Expiry Date1.34Intrinsic Value100Multiplier0DDays to Expiry0.06Time Value100Contract SizeAmericanOptions Type-0.8781Delta0.1912Gamma9.76Leverage Ratio-0.1092Theta-0.0003Rho-8.57Eff Leverage0.0014Vega
Intraday
- 5D
- 1D
News
Insider Sale: Director Richard Berman Sells 8,105 Shares of CryoPort Inc (CYRX)
Cryoport(CYRX.US) Director Sells US$108.69K in Common Stock
$Cryoport(CYRX.US)$ Director BERMAN RICHARD J sold 8,105 shares of common stock on May 15, 2024 at an average price of $13.4106 for a total value of $108.69K.Source: Announcement What is statement of
Cryoport(CYRX.US) Officer Sells US$46,042.21 in Common Stock
$Cryoport(CYRX.US)$ Officer ZECCHINI EDWARD J sold 3,443 shares of common stock on May 14, 2024 at an average price of $13.3727 for a total value of $46,042.21.Source: Announcement What is statement o
Form 144 | Cryoport(CYRX.US) Director Proposes to Sell 108.69K in Common Stocks
SEC FILLINGS DISCLOSED/ May 15, $Cryoport(CYRX.US)$ Director RICHARD J. BERMAN intends to sell 8,105 shares of its common stock on May 15, with a total market value of approximately $108.69K. Sourc
Cryoport, Inc.'s (NASDAQ:CYRX) CEO Compensation Looks Acceptable To Us And Here's Why
It's Down 29% But Cryoport, Inc. (NASDAQ:CYRX) Could Be Riskier Than It Looks
Cryoport, Inc. (NASDAQ:CYRX) shareholders won't be pleased to see that the share price has had a very rough month, dropping 29% and undoing the prior period's positive performance. The drop over th
Comments
Despite Cryoport's superior revenue outlook, its P/S ratio is not reflecting this positive outlook, suggesting that the market may be pricing in some risks. If the analysts' forecasts are accurate, the stock could be undervalued at its current price.
Cryoport, Inc.'s (NASDAQ:CYRX) Shares Not Telling The Full StoryInsider selling at Cryoport, Inc. over the past year, especially in recent months, may worry shareholders. However, significant insider ownership indicates alignment with other shareholders. The absence of insider buying in the last three months is noteworthy.
Cryoport's debt levels appear manageable, given healthy cash reserves and short-term assets. However, meeting future obligations will hinge on its profitability, an area where the company's performance has faltered. Cryoport saw modest revenue growth and a cash outflow last year.
$AMN Healthcare Services(AMN.US$ $CBL International(BANL.US$ $Chanson International(CHSN.US$ $Cryoport(CYRX.US$ $MetLife(MET.US$ $MillerKnoll(MLKN.US$ $Nova Lifestyle(NVFY.US$ $InspireMD(NSPR.US$ $Paramount Global-B(PARA.US$ $Ryder System(R.US$ $Recursion Pharmaceuticals(RXRX.US$ $Silk Road Medical(SILK.US$ $60 Degrees Pharmaceuticals(SXTP.US$ $Uber Technologies(UBER.US$ $Victory Capital(VCTR.US$
1
Read more